Safety Study to Evaluate the Contact Sensitizing Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA

Clinical trial NCT02160587 · COMPLETED

Trial details

NCT number: NCT02160587
Sponsor: Zurex Pharma, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Surgical Site Infection

Start date: 2014-07-01
Primary completion: 2014-10-01
Enrollment: 208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.